Arena REIT has delivered a strong half-year 2025 performance, with significant profit growth driven by strategic acquisitions and development completions, while reaffirming its distribution guidance and sustainability commitments.
OncoSil Medical has secured new distribution agreements across key international markets and achieved critical regulatory milestones, while raising $8 million to fuel its growth in pancreatic cancer treatment.